Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00355498 · ClinicalTrials.gov registry record

Amyloid Plaque and Tangle Imaging in Aging and Dementia

A clinical trial, sponsored by University of California, Los Angeles.

Completed
Registry status
170
Enrollment target

NCT00355498 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 170 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00355498 has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
170 participants
Enrollment target

Study Summary

Amyloid senile plaques (SPs) and neurofibrillary tangles (NFTs) are neuropathological hallmarks of Alzheimer's disease (AD) that also accumulate in key brain regions in association with normal aging. This project will expand an established program in early detection and prevention of AD designed (1) to identify presymptomatic persons most likely to benefit from early intervention and (2) to provide an objective, noninvasive means to monitor therapeutic trials.

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2005-09
Est. Completion 2010-05

What the Registry Record Tells You About NCT00355498

The ClinicalTrials.gov registry entry for NCT00355498 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00355498 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00355498 about?

NCT00355498 is a clinical study titled "Amyloid Plaque and Tangle Imaging in Aging and Dementia". Amyloid senile plaques (SPs) and neurofibrillary tangles (NFTs) are neuropathological hallmarks of Alzheimer's disease (AD) that also accumulate in key brain regions in association with normal aging. This project will expand an established program in early detection and prevention of AD designed (1)...

What is the current status of trial NCT00355498?

This trial is currently completed. The enrollment target is 170 participants. The study started on 2005-09. Estimated completion is 2010-05.

Who is sponsoring clinical trial NCT00355498?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.